Abbott Diabetes Care has recalled certain glucose monitoring sensors after reports of seven deaths and more than 700 injuries possibly linked to malfunctioning devices that could provide inaccurate ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. The Food and Drug Administration seal is seen at ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

Abbot has issued a medical device correction for some of its glucose sensor products after identifying a manufacturing issue that can lead to falsely low glucose readings. The correction affects about ...

Abbott recalled three million glucose sensors over inaccurate low readings. FreeStyle Libre 3 and 3 Plus sensors caused 736 severe events, including seven deaths worldwide. Users should check their ...

The researchers’ custom near-infrared LED heating system activates SnOx nanoflakes that heat and neutralize cancer cells (green: live cells; red: cells killed by photothermal therapy). Credit: ACS ...

The US FDA has granted a De Novo Classification for the Biolinq Shine, a novel real-time glucose sensor for people with type 2 diabetes (T2D) not on insulin. The new classification allows the company ...

After raising $100 million in venture capital funding earlier this year, Biolinq has obtained a groundbreaking green light from the FDA for its needle-free continuous glucose monitor. The Shine system ...

Biolinq is led by CEO Rich Yang, a former manager at Dexcom and Medtronic. The company was co-founded by Chief Technology Officer Jared Tangney, who has a background in micro-array sensor research and ...

1 Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, United States 2 Barnstable Brown Diabetes and Obesity Research Center, University of Kentucky, Lexington, ...